Please enable JavaScript to continue using this application.

Compare $APLM vs $RNXT | Chartloom

Compare

$APLM vs $RNXT

Apollomics Inc · RenovoRx Inc

APLM

Apollomics Inc

RNXT

RenovoRx Inc

Compare $APLM vs $RNXT

Comparing Apollomics Inc and RenovoRx Inc

APLMApollomics Inc

RNXTRenovoRx Inc

APLMApollomics Inc

Market cap

$47M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

11.4%

52W performance

413.1%

FCF yield

-1.7%

RNXTRenovoRx Inc

Market cap

$58M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

8.70x

Rev growth (TTM)

198.5%

YTD performance

53.3%

52W performance

5.8%

FCF yield

-20.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APLM

RNXT

Detailed metrics comparison

APLM

Apollomics Inc

RNXT

RenovoRx Inc

Market Cap

APLM$47M

RNXT$58M

Enterprise Value

APLM$47M

RNXT$48M

Price

APLM$21.50

RNXT$1.28

P/E Ratio

APLMN/A

RNXTN/A

P/S Ratio

APLM0.00x

RNXT29.18x

EV/Sales

APLM0.00x

RNXT24.39x

EV/EBITDA

APLM0.00x

RNXT0.00x

P/B Ratio

APLM13.94x

RNXT7.94x

P/FCF Ratio

APLMN/A

RNXTN/A

EV/FCF

APLM-57.95x

RNXT-4.04x

PEG Ratio

APLMN/A

RNXTN/A

Forward P/E (NTM)

APLMN/A

RNXTN/A

Forward P/S (NTM)

APLMN/A

RNXT8.70x

Revenue (TTM)

APLM$0

RNXT$2M

Revenue Growth (YoY)

APLMN/A

RNXT198.5%

Forward Rev Growth

APLM0.0%

RNXT195.2%

Gross Margin (TTM)

APLM0.0%

RNXT84.4%

Operating Margin (TTM)

APLM0.0%

RNXT0.0%

EBITDA Margin (TTM)

APLM0.0%

RNXT-684.9%

Net Margin (TTM)

APLM0.0%

RNXT-621.7%

FCF Margin (TTM)

APLMN/A

RNXT-604.1%

Net Income (TTM)

APLM$-823K

RNXT$-12M

FCF (TTM)

APLM$-814K

RNXT$-12M

EPS (TTM)

APLM-$0.06

RNXT-$0.26

ROE (TTM)

APLM-69339.0%

RNXT-14563.0%

ROA (TTM)

APLM-26328.0%

RNXT-10984.0%

ROIC (TTM)

APLM-56760.0%

RNXT-14563.0%

Cash

APLM$134K

RNXT$9M

Debt

APLM$0

RNXT$0

Net Cash/Debt

APLM$134K

RNXT$9M

Current Ratio (TTM)

APLM0.96x

RNXT5.74x

Quick Ratio (TTM)

APLM0.88x

RNXT5.37x

Debt/Equity (TTM)

APLM0.20x

RNXT0.00x

Debt/Assets (TTM)

APLM0.0%

RNXT0.0%

Interest Coverage (TTM)

APLMN/A

RNXTN/A

Net Debt/EBITDA (TTM)

APLM0.00x

RNXT0.00x

Beta

APLM1.37

RNXT1.07

52W Performance

APLM413.1%

RNXT5.8%

YTD Performance

APLM11.4%

RNXT53.3%

% from 52W High

APLM-49.0%

RNXT-50.6%

% from 52W Low

APLM410.7%

RNXT82.7%

Asset Turnover (TTM)

APLM0.00x

RNXT0.18x

FCF Yield (TTM)

APLM-1.7%

RNXT-20.7%

Earnings Yield (TTM)

APLM-1.7%

RNXT-21.3%

Dividend Yield (TTM)

APLMN/A

RNXTN/A

Rule of 40

APLM0.0

RNXT-405.6

EV/GP/RG

APLMN/A

RNXT0.12

Ticker research

View APLM research View RNXT research

Metric	APLM Apollomics Inc	RNXT RenovoRx Inc
Market & Valuation
Market Cap	$47M	$58M
Enterprise Value	$47M	$48M
Price	$21.50	$1.28
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	29.18x
EV/Sales	0.00x	24.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.94x	7.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-57.95x	-4.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	8.70x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	198.5%
Forward Rev Growth	0.0%	195.2%
Profitability
Gross Margin (TTM)	0.0%	84.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-684.9%
Net Margin (TTM)	0.0%	-621.7%
FCF Margin (TTM)	N/A	-604.1%
Net Income (TTM)	$-823K	$-12M
FCF (TTM)	$-814K	$-12M
EPS (TTM)	-$0.06	-$0.26
ROE (TTM)	-69339.0%	-14563.0%
ROA (TTM)	-26328.0%	-10984.0%
ROIC (TTM)	-56760.0%	-14563.0%
Financial Health
Cash	$134K	$9M
Debt	$0	$0
Net Cash/Debt	$134K	$9M
Current Ratio (TTM)	0.96x	5.74x
Quick Ratio (TTM)	0.88x	5.37x
Debt/Equity (TTM)	0.20x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	1.07
52W Performance	413.1%	5.8%
YTD Performance	11.4%	53.3%
% from 52W High	-49.0%	-50.6%
% from 52W Low	410.7%	82.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.18x
FCF Yield (TTM)	-1.7%	-20.7%
Earnings Yield (TTM)	-1.7%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-405.6
EV/GP/RG	N/A	0.12
Ticker research	View APLM research	View RNXT research

Valuation

P/S Ratio

APLM

0.00x

RNXT

29.18x

EV/FCF

APLM

-57.95x

RNXT

-4.04x

Growth & revenue

Revenue Growth TTM

RNXT

198.5%

Forward Revenue Growth

RNXT

195.2%

APLM

0.0%

Profitability & performance

Gross Margin

RNXT

84.4%

APLM

0.0%

ROE

RNXT

-14563.0%

APLM

-69339.0%

FCF Yield %

APLM

-1.7%

RNXT

-20.7%

52-Week Performance

APLM

413.1%

RNXT

5.8%

Detailed metrics comparison

APLM

Apollomics Inc

RNXT

RenovoRx Inc

Market Cap

APLM$47M

RNXT$58M

Enterprise Value

APLM$47M

RNXT$48M

Price

APLM$21.50

RNXT$1.28

P/E Ratio

APLMN/A

RNXTN/A

P/S Ratio

APLM0.00x

RNXT29.18x

EV/Sales

APLM0.00x

RNXT24.39x

EV/EBITDA

APLM0.00x

RNXT0.00x

P/B Ratio

APLM13.94x

RNXT7.94x

P/FCF Ratio

APLMN/A

RNXTN/A

EV/FCF

APLM-57.95x

RNXT-4.04x

PEG Ratio

APLMN/A

RNXTN/A

Forward P/E (NTM)

APLMN/A

RNXTN/A

Forward P/S (NTM)

APLMN/A

RNXT8.70x

Revenue (TTM)

APLM$0

RNXT$2M

Revenue Growth (YoY)

APLMN/A

RNXT198.5%

Forward Rev Growth

APLM0.0%

RNXT195.2%

Gross Margin (TTM)

APLM0.0%

RNXT84.4%

Operating Margin (TTM)

APLM0.0%

RNXT0.0%

EBITDA Margin (TTM)

APLM0.0%

RNXT-684.9%

Net Margin (TTM)

APLM0.0%

RNXT-621.7%

FCF Margin (TTM)

APLMN/A

RNXT-604.1%

Net Income (TTM)

APLM$-823K

RNXT$-12M

FCF (TTM)

APLM$-814K

RNXT$-12M

EPS (TTM)

APLM-$0.06

RNXT-$0.26

ROE (TTM)

APLM-69339.0%

RNXT-14563.0%

ROA (TTM)

APLM-26328.0%

RNXT-10984.0%

ROIC (TTM)

APLM-56760.0%

RNXT-14563.0%

Cash

APLM$134K

RNXT$9M

Debt

APLM$0

RNXT$0

Net Cash/Debt

APLM$134K

RNXT$9M

Current Ratio (TTM)

APLM0.96x

RNXT5.74x

Quick Ratio (TTM)

APLM0.88x

RNXT5.37x

Debt/Equity (TTM)

APLM0.20x

RNXT0.00x

Debt/Assets (TTM)

APLM0.0%

RNXT0.0%

Interest Coverage (TTM)

APLMN/A

RNXTN/A

Net Debt/EBITDA (TTM)

APLM0.00x

RNXT0.00x

Beta

APLM1.37

RNXT1.07

52W Performance

APLM413.1%

RNXT5.8%

YTD Performance

APLM11.4%

RNXT53.3%

% from 52W High

APLM-49.0%

RNXT-50.6%

% from 52W Low

APLM410.7%

RNXT82.7%

Asset Turnover (TTM)

APLM0.00x

RNXT0.18x

FCF Yield (TTM)

APLM-1.7%

RNXT-20.7%

Earnings Yield (TTM)

APLM-1.7%

RNXT-21.3%

Dividend Yield (TTM)

APLMN/A

RNXTN/A

Rule of 40

APLM0.0

RNXT-405.6

EV/GP/RG

APLMN/A

RNXT0.12

Ticker research

View APLM research View RNXT research

Metric	APLM Apollomics Inc	RNXT RenovoRx Inc
Market & Valuation
Market Cap	$47M	$58M
Enterprise Value	$47M	$48M
Price	$21.50	$1.28
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	29.18x
EV/Sales	0.00x	24.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.94x	7.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-57.95x	-4.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	8.70x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	198.5%
Forward Rev Growth	0.0%	195.2%
Profitability
Gross Margin (TTM)	0.0%	84.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-684.9%
Net Margin (TTM)	0.0%	-621.7%
FCF Margin (TTM)	N/A	-604.1%
Net Income (TTM)	$-823K	$-12M
FCF (TTM)	$-814K	$-12M
EPS (TTM)	-$0.06	-$0.26
ROE (TTM)	-69339.0%	-14563.0%
ROA (TTM)	-26328.0%	-10984.0%
ROIC (TTM)	-56760.0%	-14563.0%
Financial Health
Cash	$134K	$9M
Debt	$0	$0
Net Cash/Debt	$134K	$9M
Current Ratio (TTM)	0.96x	5.74x
Quick Ratio (TTM)	0.88x	5.37x
Debt/Equity (TTM)	0.20x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	1.07
52W Performance	413.1%	5.8%
YTD Performance	11.4%	53.3%
% from 52W High	-49.0%	-50.6%
% from 52W Low	410.7%	82.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.18x
FCF Yield (TTM)	-1.7%	-20.7%
Earnings Yield (TTM)	-1.7%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-405.6
EV/GP/RG	N/A	0.12
Ticker research	View APLM research	View RNXT research